Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 6, 2009, Pages 2953-2955

  Shimada, Hiroyuki ^a   Akaza, Eriko ^a   Yuzawa, Mitsuko ^a   Kawashima, Miwako ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION GRADIENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC MACULAR EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA HOLE; THICKNESS; VITRECTOMY; VITREOUS BODY; DIABETIC RETINOPATHY; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINA MACULA EDEMA; TISSUE DISTRIBUTION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MACULAR EDEMA; MIDDLE AGED; TISSUE DISTRIBUTION; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY; VITREOUS BODY;

EID: 66849091357     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2870     Document Type: Article

References (16)

1. Lund-Andersen H, Sander B. The vitreous, physiology of the eye. In: Swann DA, Constable IJ, eds. Vitreous Structure. 10th ed. St. Louis: Mosby; 2003:293-316.
2. Sander B, Larsen M, Moldow B, Lund-Andersen H. Diabetic macular edema: passive and active transport of fluorescein through the blood-retinal barrier. Invest Ophthalmol Vis Sci. 2001;42:433-438.
3. Lund-Andersen H, Krogsaa B, la Cour M, Larsen J. Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci. 1985;26:698-710.
4. Antonetti DA, Lieth E, Barber AJ, Gardner TW. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol. 1999;14:240-248.
5. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol. 1999;14:223-232.
6. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
7. Kook D, Wolf A, Kreutzer T, et al. Long-term effect of intravitreal bevacizumab (Avastin) in patients with chronic diffuse diabetic macular edema. Retina. 2008;28:1053-1060.
8. Kim I, Ryan AM, Rohan R, et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci. 1999;40:2115-2121.
9. Gilbert RE, Vranes D, Berka JL, et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest. 1998;78:1017-1027.
10. Funatsu H, Yamashita H, Nakamura S, et al. Vitreous level of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2006;113:294-301.
11. Funatsu H, Yamashita H, Shimizu E, Miura T, Nakamura S, Hori S. Quantitative measurement of retinal thickness in patients with diabetic macular edema is useful for evaluation of therapeutic agents. Diabetes Res Clin Pract. 2004;66:219-227.
12. Nguyen QD, Tatlipinar S, Shah SM, et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol. 2006 142:961-969.
13. Chun DW, Heier JS, Topping TM, Duker JS, Banker JM. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology. 2006;113:1706-1712.
14. Worst JFG. Cisternal systems of the fully developed vitreous body in the young adults. Trans Ophthalmol Soc UK. 1977;97:550-554.
15. Kishi S, Shimizu K. Posterior precortical vitreous pocket. Arch Ophthalmol. 1990;108:979-982.
16. Spaide RF. Measurement of the posterior precortical vitreous pocket in fellow eyes with posterior vitreous detachment and macular holes. Retina. 2003;23:481-485.